Biotech Startups

Clinical-stage biotech developing immuno-oncology platforms for solid tumors including glioblastoma and melanoma.

1 investor

1 investor

iTolerance develops the SA-FasL microgel (iTOL-100) immunomodulatory technology aimed at enabling cell and tissue transplantation, such as insulin-producing islet cells for diabetes, without continuous anti-rejection drugs. The company operates in regenerative medicine and transplantation immunology.

1 investor

iuvo is a contract research organization (CRO) focused exclusively on ophthalmology, managing clinical trials across anterior and posterior eye segments from protocol development through regulatory submission. It serves sponsors and innovators developing eye care drugs and ocular devices, running trials across North America and internationally.

1 investor

1 investor

iXpressGenes operates a CLIA-certified, CAP-accredited molecular diagnostics laboratory that provides genetic testing and analysis services.

1 investor

Izon Science develops nanoparticle separation and analysis instruments for biological research and nanomedicine development, including platforms for isolating extracellular vesicles and measuring physical characteristics of nano-sized particles. The company serves researchers and therapeutic developers globally with solutions ranging from individual instruments to automated, cGMP-compliant systems for industrial-scale processing.

1 investor

Greater Winston-Salem Inc. is an economic development organization for Winston-Salem/Forsyth County, North Carolina, offering business development, advocacy, networking, talent recruitment, and marketing services. It also provides memberships and career resources to attract and support companies and job seekers in the region.

1 investor

Javelin Biotech develops microphysiological systems and organ-on-chip platforms combined with digital twin software to predict drug efficacy in humans for the biopharmaceutical industry. The company offers tissue chip-based preclinical models that accelerate drug discovery by replacing traditional animal studies.

1 investor

Jazz Venture Partners is a venture capital firm whose portfolio spans companies working on human performance, health, and technology across digital therapeutics, biosciences, AI, and neuroscience. The page is a portfolio listing rather than a page for an operating company.

1 investor

JCCT is a clinical research organization that conducts hundreds of trials for biotech firms, pharmaceutical companies, and public health organizations. The company operates state-of-the-art facilities and provides comprehensive research services including participant recruitment, study management, and data management.

1 investor

Jenthera is a CRISPR therapeutics company developing gene-editing treatments based on scientific research and industry expertise.

1 investor

Jeonjin Biopharm (전진바이오팜) develops products based on natural materials, including detergents, deodorizers/air fresheners, capsule detergents (laundry and dishwasher), and animal damage-reduction agents, and offers OEM/ODM manufacturing. The South Korean company also conducts R&D in natural-material applications.

1 investor

A UK initiative that applies AI to biosecurity, aiming to strengthen the country's resilience to biological threats. It operates as the AI Biosecurity Lab, supported by government funding and company commitments.

1 investor

JITSUBO develops Molecular Hiving™, a peptide synthesis technology, and provides contract manufacturing of active pharmaceutical ingredients (APIs) and technology licensing. The company serves the pharmaceutical industry from its base in Yokohama, Japan.

1 investor

J-Land Biotech is a biotech company specializing in the industrialization and application of recombinant proteins, particularly collagen, leveraging bioengineering techniques in gene recombination, microbial fermentation, and protein purification. The company serves manufacturers, medical institutions, and end users across pharmaceuticals, medical aesthetics, cosmetics, biomimetic materials, and food sectors globally.

1 investor

Jocasta Neuroscience is a biotechnology company developing JN-0413, a proprietary subcutaneous formulation of soluble α-Klotho protein aimed at treating age-related cognitive decline and neurodegenerative diseases such as mild cognitive impairment, Alzheimer's, and Parkinson's-related dementia. The company targets brain aging at its root cause and anticipates beginning human trials in early 2027.

1 investor

Jooules produces alternative protein using microbes and gaseous fermentation to address sustainability challenges in the food sector. The company serves food producers and processors seeking efficient, bioscience-based protein production methods.

1 investor

Psychedelic therapies for addiction.

1 investor

A blog-style page discussing laboratory testing and nutritional value analysis of dietary supplements, aimed at supplement manufacturers seeking to verify product label claims. The content covers quality assurance and laboratory verification of nutrient and bioactive ingredient content.

1 investor

JSLink is a biotechnology company specializing in genomic analysis services and personalized medicine, with growing operations in rare-earth permanent magnet manufacturing. The company combines genomics research with biomarker discovery and bioinformatics analysis to support drug development and personalized medical treatment.

1 investor

P95 Julius Clinical is a contract research organization that conducts clinical trials and real-world evidence programs for biotech and pharmaceutical companies, with expertise in neuroscience, infectious diseases, vaccines, and cardiovascular and metabolic diseases. The company operates globally across 25+ countries with over 500 professionals.

1 investor

Junction Bioscience develops AI-driven software that generates and tests scientific hypotheses to discover new drug candidates, with an initial focus on therapies targeting neuroinflammatory and immunological diseases.

1 investor

Junevity is a biotech company developing siRNA therapeutics based on its RESET platform, which uses transcription factor repression to restore healthy gene expression and target age-related diseases. The company applies bioinformatics, machine learning, and cellular aging research to develop treatments for metabolism and aging-related conditions.

1 investor